研究人员、临床医生、行业、政府和慈善合作伙伴齐聚一堂，庆祝澳大利亚生物医学研究的未来，最先进的悉尼生物医学加速器将于今年开始建设。 “今晚，我们有机会庆祝悉尼大学和悉尼地方卫生区之间的长期合作关系，以及这一合作关系的下一阶段-悉尼生物医学加速器，”副校长（研究）emma johnston教授在2月13日（星期二）的晚宴开幕式上说。 “我们的目标是创建一个全球公认的健康和医学研究开发和翻译区。 georgina long教授、陈希武部长、emma johnston教授和richardscolyer教授一个由新南威尔士州政府、悉尼地方卫生区和悉尼大学共同资助的合作项目，价值6.5亿美元的悉尼生物医学加速器将加快生物医学研究和发现转化为新的医疗保健解决方案，并改善我们社区的健康结果。 尊敬的创新、科学和技术部长阿努勒克·昌提冯议员谈到了sba的社会和经济效益。 “sba对人民和我们的国家有很多重要的好处。 从它将创造的数千个就业机会，到研究和拨款的增加。 但在我看来，这并不能衡量sba的真正价值。 他说：“对sba的投资意味着对我们对学习、科学和发现的热爱的投资，这将改善生活，真正创造一个更美好的社会。”。 这次盛会提供了一个机会来了解sba的愿景，它是澳大利亚第一个真正将分子和细胞水平的基础研究与临床和以患者为中心的研究和健康结果相结合的地区。 teresa anderson博士发表演讲悉尼地方卫生区首席执行官teresa anderson博士表示，悉尼生物医学加速器将是我们社区、澳大利亚和全球的一项变革性举措。 “sba将把人类各种疾病的临床医生、研究人员、学者和工程师组成的多元化团队团结起来，加速将生物医学发现转化为当今和未来最复杂疾病的解决方案。 “嘉宾们还听取了包括2024名年度澳大利亚人、georgina long教授和richard scolyer教授在内的主要研究人员关于sba对我们一些最复杂的健康挑战可能意味着什么，包括癌症、视觉科学、心血管和呼吸系统疾病。 年度澳大利亚人乔治娜·朗教授和理查德·斯科勒教授就sba的重要性发表讲话。 在谈到他将黑色素瘤科学应用于治疗胶质母细胞瘤的历程时，斯考利耶教授说：“这就是为什么我们对加速器雄心勃勃的原因，因为我们知道我们并没有治愈尽可能多的癌症，现在是癌症研究领域，甚至所有医学研究，都会雄心勃勃，变得勇敢。 龙教授说：“当癌症研究人员和临床医生在科学的基础上勇敢地准备挑战现状时，我们在一个病人和一个肿瘤的基础上取得的进展只是冰山一角。 至关重要的是，团队合作是成功的基础。 我们对加速器很有野心，因为它的模型可以推动多学科团队的合作。 “sba将于2027年开放，占地36000米，由两座新建筑组成，这两座建筑将横跨大学的露营校园和该地区的皇家王子阿尔弗雷德医院校园，在140多年的合作关系中首次将这些机构物理连接起来。 百年研究所是sba的第一个研究合作者。 悉尼大学校园内的新建筑将被称为isaac-wakil生物医学大楼（28000米），以表彰苏珊和isaac-wachil基金会为成立sba而捐赠的2000万美元。 sba将容纳1200名生物医学研究人员和临床科学家，包括专门建造的设施，将发现从台式机转移到床边，包括湿实验室、生物库、用于医疗设备和植入物开发的原型核心研究设施、良好制造规范（gmp）洁净室、临床试验和面向患者的空间。 作为世界领先的医院、大学和技术创新生态系统的一部分，sba拥有独特的全球生物医学研究人才集中地，将实现与行业和初创企业的动态合作。 悉尼地方卫生区的teresa anderson博士与悉尼大学的robyn ward教授、emma johnston教授和annamarie jagose教授。 教务长兼副校长annamarie jagose教授感谢sba的创始捐赠者——苏珊和伊萨克·瓦基尔基金会、medich基金会、clearbridge基金会、marie knispel博士遗赠和匿名捐赠者——他们的变革性支持使sba成为现实。 她还感谢来自悉尼大学、悉尼地方卫生区、阿尔弗雷德王子医院和百年纪念研究所的数百名工作人员，他们为该设施的规划做出了贡献。 她说：“我们都为sba的完成感到无比兴奋，这不仅对相关组织，而且对整个社区和其他方面都意味着和实现。”。 galafoyer展示了3d打印的展示，描绘了关键的研究挑战和能力，以及sba的模型。researchers, clinicians, industry, government and philanthropic partners have come together to celebrate the future of biomedical research in australia, with construction of the state-of-the-art sydney biomedical accelerator set to begin this year.“tonight, we have the opportunity to celebrate the long-standing partnership between the university of sydney and sydney local health district, and the next stage in this partnership - the sydney biomedical accelerator,” said professor emma johnston, deputy vice-chancellor (research) as she opened the gala dinner event on tuesday 13 february.“our ambition is to create a globally recognised precinct for the development and translation of health and medical research.”professor georgina long, minister anoulack chanthivong, professor emma johnston and professor richard scolyer a co-funded partnership project between the nsw government, sydney local health district and the university of sydney, the $650 million sydney biomedical accelerator (sba) will accelerate the translation of biomedical research and discovery into new healthcare solutions and improved health outcomes for our community.the honourable anoulack chanthivong mp, minister for innovation, science and technology spoke to the societal and economic benefits of the sba. “there are so many key benefits of the sba to the people and to our country. from the many thousands of jobs it will create, to the increase in research and grant funding. but in my view that doesn’t measure the true value of the sba. investment in the sba means investment in our love of learning, of science and discovery which will improve lives and indeed create a better society,” he said.the gala provided the opportunity to learn about the vision for the sba as a first-in-australia precinct that genuinely integrates fundamental research at the molecular and cellular level with clinical and patient-centred research and health outcomes.dr teresa anderson giving her addresschief executive of sydney local health district dr teresa anderson said the sydney biomedical accelerator will be a transformative initiative for our community, for australia, and globally.“the sba will unite a diverse workforce of clinicians, researchers, academics, and engineers across the broad spectrum of human diseases to accelerate the translation of biomedical discovery into solutions of the most complex diseases of today and tomorrow.” guests also heard from leading researchers, including 2024 australians of the year, professor georgina long and professor richard scolyer, about what the sba could mean for some of our most complex health challenges, including cancer, vision science, cardiovascular and respiratory diseases.australians of the year, professor georgina long and professor richard scoyler speak on the importance of the sba.speaking of his journey applying melanoma science to the treatment of his own glioblastoma, professor scolyer said: “this is why we are ambitious for the accelerator because we know we’re not curing as many cancers as we could and its time the cancer research field, and indeed all medical research, thinks big and gets courageous.”professor long said:“ our advances based on one single patient and one single tumour are the tip of the iceberg of what can be achieved when cancer researchers and clinicians, underpinned by science, are brave and prepared to challenge the status quo. and critically it is teamwork that underpins success. we are ambitious for the accelerator because its model can advance bringing multidisciplinary teams together.“due to open in 2027, the sba will cover 36,000m and consist of two new buildings that will span both the university’s camperdown campus and the district’s royal prince alfred hospital campus, physically connecting these institutions for the first time in their over 140-year partnership. the centenary institute is the first research collaborator of the sba. the new building on the university of sydney campus will be known as the isaac wakil biomedical building (28,000m) in recognition of the transformative $20 million donation from the susan and isaac wakil foundation towards the establishment of the sba.housing 1,200 biomedical researchers and clinical scientists, the sba will include purpose-built facilities to transition discoveries from bench to bedside including wet labs, a biobank, a prototyping core research facility for medical devices and implant development, good manufacturing practice (gmp) cleanrooms, and clinical trial and patient-facing spaces.with a unique global concentration of biomedical research talent, the sba will enable dynamic collaboration with industry and start-ups as part of a world-leading hospital, university, and tech innovation ecosystem.dr teresa anderson of sydney local health district with the university of sydneys professor robyn ward, professor emma johnston and professor annamarie jagose.provost and deputy vice-chancellor, professor annamarie jagose acknowledged the founding donors of the sba - the susan and isaac wakil foundation, medich foundation, clearbridge foundation, the dr marie knispel bequest and anonymous donors – for their transformative support that has allowed sba to become a reality. she also thanked the hundreds of staff from across the university, sydney local health district, royal prince alfred hospital and centenary institute who contributed to planning for the facility. “we are all incredibly excited for the sba’s completion and all that it could mean and achieve for not just the organisations involved, but for the entire community and beyond,” she said. the gala foyer featured 3d-printed displays depicting key research challenges and capabilities, alongside a model of the sba.本文来源： 展望生物医学研究与创新的未来
亲，点击此处在线申请留学咨询服务和报名评估！我们将竭诚提供最佳评估服务！
